Authors' conclusions: This updated evaluation reinforces the conclusion of the first 2003 Cochrane Assessment that sublingual immunotherapy is productive for allergic rhinitis and has become demonstrated to generally be a safe route of administrationAnd those symptoms can be a lot more than just a nuisance: Study revealed from the February 2014 sit